Clinical Trials Logo
  1. Home
  2. Other
  3. NCT06127186
  4. Details
NCT06127186 Clinical Trial

Phenotype of Headache and Facial Pain in Upper Respiratory Tract Infections

Upper Respiratory Tract Infections Clinical Trial

Official title:
Phenotype of Headache and Facial Pain in Upper Respiratory Tract Infections - a Cross-sectional Study in Primary Care Setting

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT06127186
Other study ID # URTI HA FP
Secondary ID
Status Completed
Phase
First received
Last updated
Start date November 1, 2023
Est. completion date March 31, 2024

Study information
Verified date April 2024
Source Swiat Zdrowia
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The goal of this longitudinal study is to assess headache and facial pain features in patients with upper respiratory tract infections (URTI). The main question it aims to answer are: 1. What is the phenotype of headache / facial pain in URTIs 2. Does the above mentioned phenotype is associated with: 1. aetiologic factor (virus), 2. type of URTI 3. headache/facial pain experienced by patients in the past. Participants will: - answer standardized questions, - undergo physical examination, - have a swab test performend for antigens of common viruses causing URTI.

Recruitment information / eligibility
Status Completed
Enrollment 223
Est. completion date March 31, 2024
Est. primary completion date March 31, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - URTI confirmed by primary care physician - Informed consent to participate in the study Exclusion Criteria: - chronic or recurrent upper respiratory tract disorders - neoplasms - signs or symptoms of a serious neurologic or psychiatric disorder.

Study Design

Related Conditions & MeSH terms

Intervention

Diagnostic Test:
• Swab test for viral antigens
No intervention except for a routine examination and viral testing is planned.

Locations
Country Name City State
Poland Marcin Straburzynski Dzwierzuty Warminsko-mazurskie

Sponsors (1)
Lead Sponsor Collaborator
Marcin Straburzynski

Country where clinical trial is conducted

Poland, 

Outcome
Type Measure Description Time frame Safety issue
Primary Percentage of patients with one of the specified pain phenotypes Percentage of patients with one of the specified pain phenotypes (migraine-like/tension-type-like/trigeminal cephalalgia-like) A single assessment during primary care physician office 1 day visit.
See also
  Status Clinical Trial Phase
Completed NCT01158560 - A Trial of Vitamin D and Health Advice for the Prevention of Upper Respiratory Tract Infections Phase 3
Completed NCT00965822 - A Randomized, Double-blind, Placebo-controlled Study on the Efficacy and Safety of CVT-E002 in the Treatment of Upper Respiratory Tract Infections in a Pediatric (3-11 Years) Population Phase 2
Completed NCT01019889 - Effect of Socheongryong-tang and Yeongyopaedok-san in Upper Respiratory Tract Infection Phase 3
Not yet recruiting NCT05484102 - Preventive Effect of Cow's Milk Fermented With Lactobacillus Paracasei CBA L74 on Common Infectious Diseases in Children N/A
Recruiting NCT05804123 - LiveSpo Navax® Supports the Treatment of Acute Rhinosinusitis and Otitis Media N/A
Completed NCT01773824 - Routine Prescription Feedback and Peer Comparison to Lower Antibiotic Prescriptions in Primary Care N/A
Terminated NCT01964885 - Benefit and Tolerability of IQP-AS-105 in Reducing Susceptibility to Upper Respiratory Tract Infections Phase 3
Completed NCT01883427 - Nasal Spray With Glucose Oxidase Preventing Common Cold in Pre-school Children Phase 2
Completed NCT01215682 - Vitamin D Supplementation and Upper Respiratory Tract Infections in Adolescent Swimmers N/A
Completed NCT04019730 - The Effect of a Ketogenic Diet on the Exercise Induced Immune Response N/A
Completed NCT01604096 - Controlled Trial to Evaluate a Local Information Campaign on Antibiotic Prescribing in Italy Phase 2
Recruiting NCT06149494 - RCT of Vapendavir in Patients With COPD and Human Rhinovirus/Enterovirus Upper Respiratory Infection Phase 2
Completed NCT03463694 - Edinburgh and Lothian Virus Intervention Study in Kids N/A
Completed NCT03198676 - A Safety Study to Compare the Effect of Two PrEP-001 Nasal Powder Formulations on Nasal Mucosa and Serum Cytokine Production Phase 1
Withdrawn NCT05557214 - Reducing Unnecessary Antibiotic Prescriptions in Primary Healthcare in Saskatchewan by Identifying High Prescribers N/A
Completed NCT01893762 - Innate Immune Response to (An)Aerobic Exercise in Rowing Athletes N/A
Completed NCT01396889 - Impact of Echinacea as Prophilaxis for Upper Respiratory Tract Infections in Children 1-5 Years N/A
Completed NCT01129128 - Three Arm Trial of Immune Effects of Echinacea N/A
Completed NCT05252468 - COVID-19 Prevention Trial: Effect of Prophylactic Use of TAFFIX™ on Infection Rate by SARS-CoV-2 Virus (COVID-19). N/A
Terminated NCT05279534 - Efficacy and Safety of L. Plantarum and P. Acidilactici in Children With Upper Respiratory Tract Infections N/A